Is a full-body MRI scan worthwhile as a preventive measure?
For healthy people without elevated risk, the added value of a full-body MRI has not yet been proven: many detected abnormalities are benign and we do not know whether early detection actually saves lives. If you are still considering it, discuss the pros and cons with your doctor first.
In people without any symptoms, a full-body MRI actually detects cancer in an average of 1.6 out of every 100 people scanned. That sounds low, but these are people with no symptoms at all. Whether that early detection also leads to fewer deaths or a longer life has not been demonstrated: data on long-term outcomes and cost-effectiveness are entirely lacking.
The downsides are considerable. Almost everyone who is scanned is told about at least one abnormal finding. Three in ten people scanned are referred for further investigation. Of all reported abnormalities, 91% turned out to be benign. Unnecessary anxiety and additional investigations are therefore a real risk.
A classification system exists that helps radiologists categorise findings by severity. In the highest-risk categories, the probability of genuine cancer is 43 to 75%; in the lowest category it is just 0.1%. Only 2.1% of people scanned fall into those higher-risk categories. This system may help reduce unnecessary referrals, but has not yet been widely validated.
Long-term psychological harm appears to be limited, as shown by a small study of 121 participants. There was a slight increase in depressive symptoms after one year, but this was not related to the number or severity of abnormalities found. People with certain personality traits were more vulnerable to stress following such a scan.
There is one group for whom the balance is clearly different: people with a rare inherited predisposition that confers an extremely high cancer risk (Li-Fraumeni syndrome). In that group, regular surveillance including a full-body MRI was linked to a five-year survival rate of 88.8%, compared with 59.6% in people who were not monitored. That is a very different situation from screening in the average healthy person. If this condition runs in your family, discuss with your doctor whether targeted surveillance makes sense for you.
This answer draws on multiple studies, including a summary of nine studies involving more than nine thousand participants and various individual investigations. The evidence on detection rates is reasonably consistent, but most studies carry a moderate to serious risk of bias and the MRI protocols used vary considerably. Data on the genuine added value, such as reduced mortality or better survival in the general population, are entirely absent. The researchers themselves emphasise that this is a major gap. The findings on psychological consequences come from a small study of 121 participants and should therefore be considered preliminary.
Which cancer screenings are worthwhile, and from what age?
Colorectal cancer screening from age 50 and mammography from age 40 have the best evidence base for the average person; lung cancer screening is only relevant if you have a heavy smoking history. Other screenings are only worthwhile in the presence of specific risk factors or inherited conditions.
Does bowel cancer screening really help (fewer deaths)?
For people between 45 and 75 with an average risk, bowel cancer screening is worthwhile and widely recommended. It demonstrably lowers the chance of developing bowel cancer, although the evidence for reducing deaths in the short term is less definitive than previously thought.
Which health checks are genuinely worthwhile and which are a waste of money?
Cervical cancer screening (ages 21-65) and lung cancer screening (ages 50-80, 20+ pack-years) have the strongest evidence base and are worthwhile. PSA screening is a personal trade-off: the benefit is small and the side effects of overtreatment are measurable.
Is breast cancer screening worth it?
Participating in breast cancer screening may offer a small benefit, but the chance of unnecessary treatment or a false-positive result is real. Consider what matters most to you, and discuss it with your GP if you are unsure.
Is it true that circumcision protects against penile cancer and HPV?
Circumcision early in life is associated with a clearly lower risk of invasive penile cancer and a reduced likelihood of carrying HPV, but part of that protection operates through the prevention of phimosis. HPV vaccination is a better-supported prevention step for most people.
How can you detect melanoma early?
The best way to detect melanoma early is to check your skin regularly, know the ABCDE features, and consult a dermatologist if in doubt, especially if you have fair skin or a family history of melanoma.